Assessing the Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses

The purpose of this clinical trial is to assess the clinical performance of LID# 223194 Multifocal (MF) contact lens and a commercially available Air Optix plus HydraGlyde (AOHG) MF contact lens. Eligible subjects will wear each study lens type in a cross-over fashion as randomized for approximately 2 days.

Key Inclusion Criteria:Able to understand and sign an consent form (ICF) that has been approved by an Institutional Review Board (IRB);Willing to stop wearing habitual contact lenses for the duration of study participation;Currently wearing multifocal soft contact lenses in both eyes for a minimum of 5 days per week and 8 hours per day during the past 3 months;Other protocol-defined inclusion criteria may apply.Key Exclusion Criteria:Any eye infection, inflammation, or abnormality or disease (including systemic) that contraindicates contact lens wear, as determined by the investigator;Any use of systemic or ocular medications for which contact lens wear could be contraindicated, as determined by the investigator;History of refractive surgery, or plan to have refractive surgery during the study;Current or history of dry eye in either eye that would preclude contact lens wear, in the opinion of the investigator;Monovision contact lens wear;Other protocol-defined exclusion criteria may apply.